Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Laux

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 25, 2018
Synthesis and structure‑activity‑relationship of 3,4‑Diaryl‑1H‑pyrrolo[2,3‑b]pyridines as irreversible Inhibitors of mutant EGFR‑L858R/T790MMarcel Günther, Julian Laux, Stefan Laufer
ACS Pharmacology & Translational Science|June 16, 2023
Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α RatioJulian Laux, Mariella Martorelli, Nadja Späth, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Inherent Fluorescence Demonstrates Immunotropic Properties for Novel Janus Kinase 3 InhibitorsJulian Laux, Mariella Martorelli, Simon Strass, et al.
ACS Pharmacology & Translational Science|August 19, 2022
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune CellsJulian Laux, Michael Forster, Laura Riexinger, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 25, 2018
Synthesis and structure‑activity‑relationship of 3,4‑Diaryl‑1H‑pyrrolo[2,3‑b]pyridines as irreversible Inhibitors of mutant EGFR‑L858R/T790MMarcel Günther, Julian Laux, Stefan Laufer
ACS Pharmacology & Translational Science|June 16, 2023
Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α RatioJulian Laux, Mariella Martorelli, Nadja Späth, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Inherent Fluorescence Demonstrates Immunotropic Properties for Novel Janus Kinase 3 InhibitorsJulian Laux, Mariella Martorelli, Simon Strass, et al.
ACS Pharmacology & Translational Science|August 19, 2022
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune CellsJulian Laux, Michael Forster, Laura Riexinger, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Pageof 1